Search Saint Luke's

For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests.

Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.

After ending up in the hospital with a stress-induced heart issue, Louise stayed optimistic and made lifestyle changes to turn her health around.

The University of Missouri–Kansas City (UMKC) School of Medicine opened in 1971 as the result of more than a decade of community efforts to establish a medical school in Kansas City, Missouri.

When she needed a heart transplant, she choose Saint Luke’s Mid America Heart Institute. A year later, Jenna’s feeling healthy and strong and advocating for improvements to medical devices for women.

Opt in for email 

Hypertension

The Global Paradise® System US Post Approval Study

USA Today talked to Dr. Paul Chan about disparities found when analyzing the effectiveness of bystander CPR for cardiac arrest.

Ahead of American Heart Month, USA Today talks with Dr. James O’Keefe of the Saint Luke’s Mid America Heart Institute about five steps you can take to reduce your risk of developing heart disease.

USA Today invited Ginny Boos, director of infection prevention at Saint Luke’s, to discuss what the TB outbreak means for Chiefs fans.